Literature DB >> 20059646

Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.

G Oberdörster1.   

Abstract

Nanotechnology, nanomedicine and nanotoxicology are complementary disciplines aimed at the betterment of human life. However, concerns have been expressed about risks posed by engineered nanomaterials (ENMs), their potential to cause undesirable effects, contaminate the environment and adversely affect susceptible parts of the population. Information about toxicity and biokinetics of nano-enabled products combined with the knowledge of unintentional human and environmental exposure or intentional delivery for medicinal purposes will be necessary to determine real or perceived risks of nanomaterials. Yet, results of toxicological studies using only extraordinarily high experimental doses have to be interpreted with caution. Key concepts of nanotoxicology are addressed, including significance of dose, dose rate, and biokinetics, which are exemplified by specific findings of ENM toxicity, and by discussing the importance of detailed physico-chemical characterization of nanoparticles, specifically surface properties. Thorough evaluation of desirable versus adverse effects is required for safe applications of ENMs, and major challenges lie ahead to answer key questions of nanotoxicology. Foremost are assessment of human and environmental exposure, and biokinetics or pharmacokinetics, identification of potential hazards, and biopersistence in cells and subcellular structures to perform meaningful risk assessments. A specific example of multiwalled carbon nanotubes (MWCNT) illustrates the difficulty of extrapolating toxicological results. MWCNT were found to cause asbestos-like effects of the mesothelium following intracavitary injection of high doses in rodents. The important question of whether inhaled MWCNT will translocate to sensitive mesothelial sites has not been answered yet. Even without being able to perform a quantitative risk assessment for ENMs, due to the lack of sufficient data on exposure, biokinetics and organ toxicity, until we know better it should be made mandatory to prevent exposure by appropriate precautionary measures/regulations and practicing best industrial hygiene to avoid future horror scenarios from environmental or occupational exposures. Similarly, safety assessment for medical applications as key contribution of nanotoxicology to nanomedicine relies heavily on nano-specific toxicological concepts and findings and on a multidisciplinary collaborative approach involving material scientists, physicians and toxicologists.

Entities:  

Mesh:

Year:  2010        PMID: 20059646     DOI: 10.1111/j.1365-2796.2009.02187.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  170 in total

Review 1.  Functionalized carbon nanotubes for potential medicinal applications.

Authors:  Yi Zhang; Yuhong Bai; Bing Yan
Journal:  Drug Discov Today       Date:  2010-05-06       Impact factor: 7.851

2.  Photodynamic therapy with fullerenes in vivo: reality or a dream?

Authors:  Sulbha K Sharma; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2011-12       Impact factor: 5.307

3.  Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.

Authors:  Jong Ah Kim; Christoffer Åberg; Anna Salvati; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

4.  Nanoparticles in the lung.

Authors:  Wolfgang G Kreyling; Stephanie Hirn; Carsten Schleh
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

5.  Nanobiotechnology: nanoparticle coronas take shape.

Authors:  Marco P Monopoli; Francesca Baldelli Bombelli; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2011-01       Impact factor: 39.213

Review 6.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

7.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 8.  Intracellular signal modulation by nanomaterials.

Authors:  Salik Hussain; Stavros Garantziotis; Fernando Rodrigues-Lima; Jean-Marie Dupret; Armelle Baeza-Squiban; Sonja Boland
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  Distribution and biomarkers of carbon-14-labeled fullerene C60 ([(14) C(U)]C60 ) in female rats and mice for up to 30 days after intravenous exposure.

Authors:  Susan C J Sumner; Rodney W Snyder; Christopher Wingard; Ninell P Mortensen; Nathan A Holland; Jonathan H Shannahan; Suraj Dhungana; Wimal Pathmasiri; Li Han; Anita H Lewin; Timothy R Fennell
Journal:  J Appl Toxicol       Date:  2015-02-27       Impact factor: 3.446

Review 10.  Nanotechnology: toxicologic pathology.

Authors:  Ann F Hubbs; Linda M Sargent; Dale W Porter; Tina M Sager; Bean T Chen; David G Frazer; Vincent Castranova; Krishnan Sriram; Timothy R Nurkiewicz; Steven H Reynolds; Lori A Battelli; Diane Schwegler-Berry; Walter McKinney; Kara L Fluharty; Robert R Mercer
Journal:  Toxicol Pathol       Date:  2013-02-06       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.